Researchers at the University of California San Francisco found the drug etomixir, developed to treat heart failure, to stop the growth of triple-negative breast cancer implanted in mice, suggesting a more effective method for battling the disease.
Source: Study: Fat fuels triple negative breast cancer – UPI.com